MANI Inc

Common Name
MANI
Country
Japan
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
4,154
Ticker
7730
Exchange
TOKYO STOCK EXCHANGE
Description
Mani Inc. is a prominent player in the medical instruments industry, specializing in the manufacture and distribution of precision instruments and equipment crucial for surgical, dental, and ophthalmi...

MANI's GHG Emissions Data Preview

In 2023, MANI completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, MANI has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind MANI’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore MANI’s data sources below and access millions more through our Disclosure Search.

a. MANI's Integrated Report 2023
a. MANI's Integrated Report 2023

Insights into MANI's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of MANI amounted to 17,103 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of MANI decreased by 6.17%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

MANI's Scope 1 Emissions Over Time

202220230150300450600tCO2e+9%
  • Total Scope 1
  • Year-over-Year Change

What are MANI's Scope 1 emissions?

In 2023, the total Scope 1 emissions of MANI were 481 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), MANI's Scope 1 emissions increased by 9.07%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are MANI's Scope 2 emissions?

In 2023, MANI reported Scope 2 greenhouse gas (GHG) emissions of 16,622 tCO₂e without specifying the calculation method. a

Has MANI reduced its Scope 2 emissions over time?

Compared to the previous year (2022), MANI's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that MANI 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does MANI use for Scope 2 reporting?

In 2023, MANI reported its Scope 2 emissions using an unspecified methodology. a

MANI's Scope 2 Emissions Over Time

2022202304.5 k9 k13.5 k18 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into MANI’s GHG Emissions Intensity Compared to Industry Peers

In 2023, MANI reported Scope 1 greenhouse gas (GHG) emissions of 481 tCO₂e and total revenues of USD 168 millions. This translates into an emissions intensity of 2.87 tCO₂e per millions USD. a

MANI's Scope 1 Emissions Intensity Compared to Peers

501,00020,000200,0005,000,000Scope 1 Emissions (tCO2e)505002,00010,000100,000Revenues (Millions of USD)SNMeniconYear: 2023Scope 1: 3,930 tCO2eRevenue: $M 827Scope 1 Intensity: 4.75 tCO2e/$MHoyaYear: 2023Scope 1: 11,000 tCO2eRevenue: $M 5,511Scope 1 Intensity: 2.00 tCO2e/$MTerumoYear: 2023Scope 1: 64,123 tCO2eRevenue: $M 6,158Scope 1 Intensity: 10.41 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MNihon KohdenYear: 2023Scope 1: 4,250 tCO2eRevenue: $M 1,551Scope 1 Intensity: 2.74 tCO2e/$MAsahi InteccYear: 2024Scope 1: 2,490 tCO2eRevenue: $M 669Scope 1 Intensity: 3.72 tCO2e/$MJCR PharmaceuticalsYear: 2022Scope 1: 3,315 tCO2eRevenue: $M 419Scope 1 Intensity: 7.92 tCO2e/$MPeptiDreamYear: 2023Scope 1: 3,156 tCO2eRevenue: $M 203Scope 1 Intensity: 15.55 tCO2e/$MSysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MSSSugi HoldingsYear: 2023Scope 1: 1,531 tCO2eRevenue: $M 4,898Scope 1 Intensity: 0.31 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MMatsukiyoCocokara & CoYear: 2023Scope 1: 1,764 tCO2eRevenue: $M 7,142Scope 1 Intensity: 0.25 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MSuzukenYear: 2023Scope 1: 26,491 tCO2eRevenue: $M 17,378Scope 1 Intensity: 1.52 tCO2e/$MTsuruha HoldingsYear: 2023Scope 1: 3,424 tCO2eRevenue: $M 6,940Scope 1 Intensity: 0.49 tCO2e/$MOtsuka HoldingsYear: 2021Scope 1: 1,030,000 tCO2eRevenue: $M 13,021Scope 1 Intensity: 79.10 tCO2e/$MSMSYear: 2023Scope 1: 220 tCO2eRevenue: $M 343Scope 1 Intensity: 0.64 tCO2e/$MAstellas PharmaYear: 2023Scope 1: 59,203 tCO2eRevenue: $M 11,401Scope 1 Intensity: 5.19 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MAlfresa HoldingsYear: 2023Scope 1: 32,399 tCO2eRevenue: $M 20,241Scope 1 Intensity: 1.60 tCO2e/$MTakeda PharmaceuticalYear: 2024Scope 1: 273,000 tCO2eRevenue: $M 28,155Scope 1 Intensity: 9.70 tCO2e/$MKaken PharmaceuticalYear: 2023Scope 1: 11,069 tCO2eRevenue: $M 548Scope 1 Intensity: 20.20 tCO2e/$MMANIYear: 2023Scope 1: 481 tCO2eRevenue: $M 168Scope 1 Intensity: 2.87 tCO2e/$M

How does MANI's GHG emissions intensity compare to its peers?

In 2023, MANI reported a Scope 1 emissions intensity of 2.87 tCO₂e per millions USD. Compared to the peer group median of 4.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does MANI rank on GHG emissions intensity within its industry?

In 2023, MANI ranked 10 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

MANI is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to MANI's GHG Emissions Dataset?
Sign Up